Haematological malignancy Clinical Trials

Delta Trials records 33 clinical trials for Haematological malignancy in its publicly accessible dataset. From the full dataset, 14 actively seeking eligible participants and 6 trials have reached completion. This research is conducted across 104 study locations around the world. An additional 13 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.